Revive Therapeutics Ltd (RVV.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 06-2020 | 06-2019 | 06-2018 | 06-2017 | 06-2016 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 28 | 3 | 3 | 4 | 6 |
| Accounts receivable | -101 | 0 | 2 | -2 | 46 |
| Other Working Capital | -503 | -5 | 94 | -553 | 588 |
| Other Operating Activity | -1,940 | -1,183 | -1,598 | -1,529 | -2,627 |
| Operating Cash Flow | $-2,516 | $-1,185 | $-1,498 | $-2,081 | $-1,987 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 0 | -2 | 0 | -2 |
| Purchase Of Investment | 0 | -750 | N/A | N/A | N/A |
| Sale Of Investment | 142 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -1 | -9 | -2 | N/A |
| Investing Cash Flow | $142 | $-751 | $-11 | $-2 | $-2 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 318 | N/A | N/A | N/A | N/A |
| Debt Repayment | -136 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 3,393 | 1,350 | 0 | 1,500 | 845 |
| Other Financing Activity | -295 | 0 | 801 | 1,018 | -15 |
| Financing Cash Flow | $3,280 | $1,350 | $801 | $2,518 | $829 |
| Beginning Cash Position | 475 | 1,061 | 1,769 | 1,333 | 2,492 |
| End Cash Position | 1,381 | 475 | 1,061 | 1,769 | 1,333 |
| Net Cash Flow | $906 | $-585 | $-708 | $435 | $-1,159 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,516 | -1,185 | -1,498 | -2,081 | -1,987 |
| Capital Expenditure | N/A | -1 | -11 | -2 | -2 |
| Free Cash Flow | -2,516 | -1,186 | -1,509 | -2,083 | -1,988 |